SG10201407593RA - Separation method of nucleated cells derived from bone marrow for bone formation - Google Patents
Separation method of nucleated cells derived from bone marrow for bone formationInfo
- Publication number
- SG10201407593RA SG10201407593RA SG10201407593RA SG10201407593RA SG10201407593RA SG 10201407593R A SG10201407593R A SG 10201407593RA SG 10201407593R A SG10201407593R A SG 10201407593RA SG 10201407593R A SG10201407593R A SG 10201407593RA SG 10201407593R A SG10201407593R A SG 10201407593RA
- Authority
- SG
- Singapore
- Prior art keywords
- bone
- bone marrow
- nucleated cells
- bone formation
- formation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0654—Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Rheumatology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
9 SEPARATION METHOD OF NUCLEATED CELLS DERIVED FROM BONE MARROW FOR BONE The present invention relates to a method for separating bone marrow-derived nucleated cells for bone formation. The method comprises: the steps of: washing bone marrow; lysing red blood cells in the bone marrow; neutralizing the bone marrow lysate; purifying nucleated cells from the neutralized bone marrow; and mixing the nucleated cells with maintenance a buffer for bone formation. According to the invention, bone marrow-derived nucleated cells, which can be grafted into a site in need of bone formation or bone defect treatment, can be separated in a rapid and convenient manner. As a result, bone formation in emergency patients or patients, who require repeated surgical operations, can be effectively achieved by separating the nucleated cells for bone formation in surgical locations in a convenient and rapid manner and injecting the separated cells into the patients. No suitable figure
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060043936A KR100833793B1 (en) | 2006-05-16 | 2006-05-16 | Separation method of nucleated cells derived from bone marrow for bone formation |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201407593RA true SG10201407593RA (en) | 2014-12-30 |
Family
ID=38694041
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201407593RA SG10201407593RA (en) | 2006-05-16 | 2006-06-23 | Separation method of nucleated cells derived from bone marrow for bone formation |
SG2011035201A SG172595A1 (en) | 2006-05-16 | 2006-06-23 | Separation method of nucleated cells derived from bone marrow for bone formation |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG2011035201A SG172595A1 (en) | 2006-05-16 | 2006-06-23 | Separation method of nucleated cells derived from bone marrow for bone formation |
Country Status (17)
Country | Link |
---|---|
US (1) | US20090111087A1 (en) |
EP (1) | EP2018419B1 (en) |
JP (1) | JP2009537215A (en) |
KR (1) | KR100833793B1 (en) |
CN (1) | CN101432421A (en) |
BR (1) | BRPI0621573A2 (en) |
CY (1) | CY1117747T1 (en) |
DK (1) | DK2018419T3 (en) |
ES (1) | ES2585231T3 (en) |
HR (1) | HRP20160966T1 (en) |
HU (1) | HUE029896T2 (en) |
PL (1) | PL2018419T3 (en) |
PT (1) | PT2018419T (en) |
RS (1) | RS54893B1 (en) |
SG (2) | SG10201407593RA (en) |
SI (1) | SI2018419T1 (en) |
WO (1) | WO2007132962A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104774805A (en) * | 2015-04-03 | 2015-07-15 | 银广悦 | Method for separating bone marrow mononuclear cells |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997026326A1 (en) * | 1996-01-16 | 1997-07-24 | Depuy Orthopaedics, Inc. | Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use |
US5824084A (en) * | 1996-07-03 | 1998-10-20 | The Cleveland Clinic Foundation | Method of preparing a composite bone graft |
JP4526749B2 (en) * | 1999-05-28 | 2010-08-18 | ステムセル テクノロジース インコーポレーテッド | Cell separation method using immuno rosette |
US7049093B2 (en) * | 2000-11-08 | 2006-05-23 | Sysmex Corporation | Method of classifying and counting nucleated bone marrow cells |
JP3929283B2 (en) * | 2000-11-08 | 2007-06-13 | シスメックス株式会社 | Bone marrow nucleated cell classification and counting method |
US6723131B2 (en) * | 2001-02-28 | 2004-04-20 | The Cleveland Clinic Foundation | Composite bone marrow graft material with method and kit |
JP2005506525A (en) * | 2001-07-27 | 2005-03-03 | ベックマン コールター,インコーポレーテッド | Methods for measuring nucleated red blood cells |
WO2003040064A2 (en) * | 2001-11-07 | 2003-05-15 | Bioview Ltd. | Kits and methods for preparing cell samples optimized for dual staining |
KR20030085257A (en) * | 2002-04-29 | 2003-11-05 | 주식회사 셀론텍 | A blood bag and method for separating cell using of it |
JP4087161B2 (en) * | 2002-06-21 | 2008-05-21 | シスメックス株式会社 | Methods for detecting abnormalities in lymphocyte subsets |
AU2003277610A1 (en) * | 2002-11-08 | 2004-06-07 | Shuichi Hanada | Method of examining cancer cells and reagent therefor |
JP2006055106A (en) * | 2004-08-23 | 2006-03-02 | National Institute Of Advanced Industrial & Technology | Method for culturing mesenchymal stem cell derived from human bone marrow by using human serum culture medium |
-
2006
- 2006-05-16 KR KR1020060043936A patent/KR100833793B1/en active IP Right Grant
- 2006-06-23 CN CNA200680054424XA patent/CN101432421A/en active Pending
- 2006-06-23 BR BRPI0621573-4A patent/BRPI0621573A2/en not_active Application Discontinuation
- 2006-06-23 JP JP2009510876A patent/JP2009537215A/en active Pending
- 2006-06-23 RS RS20160463A patent/RS54893B1/en unknown
- 2006-06-23 HU HUE06769014A patent/HUE029896T2/en unknown
- 2006-06-23 ES ES06769014.9T patent/ES2585231T3/en active Active
- 2006-06-23 DK DK06769014.9T patent/DK2018419T3/en active
- 2006-06-23 US US12/226,472 patent/US20090111087A1/en not_active Abandoned
- 2006-06-23 PL PL06769014.9T patent/PL2018419T3/en unknown
- 2006-06-23 SI SI200632077A patent/SI2018419T1/en unknown
- 2006-06-23 PT PT67690149T patent/PT2018419T/en unknown
- 2006-06-23 SG SG10201407593RA patent/SG10201407593RA/en unknown
- 2006-06-23 WO PCT/KR2006/002434 patent/WO2007132962A1/en active Application Filing
- 2006-06-23 EP EP06769014.9A patent/EP2018419B1/en active Active
- 2006-06-23 SG SG2011035201A patent/SG172595A1/en unknown
-
2016
- 2016-07-07 CY CY20161100644T patent/CY1117747T1/en unknown
- 2016-07-28 HR HRP20160966TT patent/HRP20160966T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP2018419A1 (en) | 2009-01-28 |
EP2018419B1 (en) | 2016-05-04 |
DK2018419T3 (en) | 2016-08-15 |
ES2585231T3 (en) | 2016-10-04 |
CY1117747T1 (en) | 2017-05-17 |
HUE029896T2 (en) | 2017-04-28 |
PT2018419T (en) | 2016-07-14 |
HRP20160966T1 (en) | 2016-11-18 |
US20090111087A1 (en) | 2009-04-30 |
EP2018419A4 (en) | 2010-07-14 |
RS54893B1 (en) | 2016-10-31 |
CN101432421A (en) | 2009-05-13 |
JP2009537215A (en) | 2009-10-29 |
KR20070111073A (en) | 2007-11-21 |
KR100833793B1 (en) | 2008-05-29 |
PL2018419T3 (en) | 2016-11-30 |
SI2018419T1 (en) | 2016-08-31 |
WO2007132962A1 (en) | 2007-11-22 |
SG172595A1 (en) | 2011-07-28 |
BRPI0621573A2 (en) | 2011-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005038012A3 (en) | Cartilage and bone repair and regeneration using postpartum-derived cells | |
WO2009059032A3 (en) | Uses and isolation of very small embryonic-like (vsel) stem cells | |
MX2009005849A (en) | Compositions and methods to treat cancer with cupredoxins and cpg rich dna. | |
WO2008051568A3 (en) | Methods and compositions for treatment of bone defects with placental cell populations | |
WO2006135915A3 (en) | Methods and compositions for treating degenerative bone disorders | |
WO2007127436A3 (en) | Methods and compositions for repairing cartilage | |
WO2007117602A3 (en) | Isolation and use of human regulatory t cells | |
WO2007092622A3 (en) | Compositions and methods for treating bone | |
EA200900806A1 (en) | METHODS OF INCREASING THE NUMBER AND MOBILIZATION OF HEMOPOETIC STEM CELLS | |
WO2009126786A3 (en) | Improved quenching methods for red blood cell pathogen inactivation | |
WO2012006100A3 (en) | Methods and compositions for enhancing stem cell mobilization | |
EP2126044A4 (en) | Stem and progenitor cell compositions recovered from bone marrow or cord blood; system and method for preparation thereof | |
WO2007041546A3 (en) | Method for selectively depleting hypoxic cells | |
WO2008127305A3 (en) | Method of isolating biomacromolecules using low ph and divalent cations | |
WO2008058233A3 (en) | In vivo bioreactors and methods of making and using same | |
WO2007054939A3 (en) | Method for non-autologous cartilage regeneration | |
MX2010005863A (en) | Process for reducing effects of graft versus host disease using ex vivo expanded cd4+cd25+ regulatory t cells. | |
WO2010097788A3 (en) | Visfatin therapeutic agents for the treatment of acne and other conditions | |
WO2007082177A3 (en) | Myeloid suppressor cells, methods for preparing them, and methods for using them for treating autoimmunity | |
WO2008066858A3 (en) | Method of separating target dna from mixed dna | |
SG10201407593RA (en) | Separation method of nucleated cells derived from bone marrow for bone formation | |
TW200510011A (en) | A method for regeneration of bone | |
WO2003029432A3 (en) | Human mesenchymal progenitor cell | |
MY160857A (en) | A cancer vaccine | |
MX2009000643A (en) | Method for collecting blood and transforming same into a hydrolyzed protein using slaughter animal blood, such as to obtain hydrolyzed blood protein. |